News
-
FOPH: Federal Council approves EU Programmes Agreement
-
Swissmedic: Swissmedic Journal 03/2025
-
Swissmedic: Appointment to the Management Committee of the IMDRF
-
FOPH: Switzerland and EU initial agreement on programmes
-
Swissmedic: Expansion of the Swissmedic position paper on real world evidence
-
Swissmedic: Addendum 11.7 of the European Pharmacopoeia enters into force
-
EMA: Publication of EU recommendations for 2025/2026 seasonal flu vaccine composition
-
EMA: Clinical Trials Information System designated as WHO primary registry
-
EMA: First report on sale and use of antimicrobials in animals in the EU
-
Swissmedic: Intensification of controls on international trade in medicinal products with suppliers from non-EU countries
-
FOPH: New platform for human research in Switzerland
-
Swissmedic: Publication of flyer on authorisations and drug safety in veterinary medicinal products
-
Swissmedic: Information on adverse drug reaction during treatment with a sartan and an NSAID
-
EMA: Establishment of regular procedure for scientific advice on certain high-risk medical devices
-
Swissmedic: Launch of Strategic Plan Access Consortium 2025 – 2028
-
EMA: Qualification of first artificial intelligence tool to diagnose inflammatory liver disease in biopsy samples
-
Swissmedic: Publication of report on authorisations of complementary and herbal medicinal products
-
EMA: Publication of EU medicine agencies’ network strategy to 2028
-
FOPH: New head of the Health Protection Directorate
-
Swissmedic: Newly appointed Swissmedic Expert Committees start work
-
EMA: First vaccine against epizootic haemorrhagic disease recommended for approval